Showing results (2011-2020 of 2,225) with videos related to

Sort By:
Pageof 223
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2025
Cognitive profiles at presentation and subsequent cognitive decline and quality of life in Parkinson's diseaseSaira S Mirza, Sarah Duff-Canning, Mark Mapstone, et al.
Neurobiology of Aging|September 2, 2014
Mutation analysis of patients with neurodegenerative disorders using NeuroX arrayMahdi Ghani, Anthony E Lang, Lorne Zinman, et al.
Neurology|April 2, 2008
Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonismE Moro, J Volkmann, I R König, et al.
NPJ Parkinson'S Disease|December 20, 2024
Multimodal oculomotor assessment reveals prodromal markers of Parkinson's disease in non-manifesting LRRK2 G2019S mutation carriersHeidi C Riek, Naomi P Visanji, Isabell C Pitigoi, et al.
Neurology|February 12, 2004
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson diseaseK Hedrich, A Djarmati, N Schäfer, et al.
Annals of Neurology|August 5, 2004
Chorein detection for the diagnosis of chorea-acanthocytosisCarol Dobson-Stone, Antonio Velayos-Baeza, Lea A Filippone, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2018
Validation of the MDS clinical diagnostic criteria for Parkinson's diseaseRonald B Postuma, Werner Poewe, Irene Litvan, et al.
Translational Psychiatry|March 24, 2024
Long-term outcomes of physical activity counseling in in-patients with major depressive disorder: results from the PACINPAT randomized controlled trialJan-Niklas Kreppke, Robyn Cody, Johannes Beck, et al.
Journal of Psychiatric Research|May 26, 2024
Cardiorespiratory fitness, perceived fitness and autonomic function in in-patients with different depression severity compared with healthy controlsJan-Niklas Kreppke, Robyn Cody, Johannes Beck, et al.
Cancers|November 11, 2022
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 SystemEvan N Cohen, Gitanjali Jayachandran, Richard G Moore, et al.
Pageof 223